Earnings · China A-shares
Zhejiang Huakang Pharmaceutical Co., Ltd. Class A (605077) earnings
Zhejiang Huakang Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -63.30% year on year, -65.17% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -5.11% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -63.30%
- Excl. one-offs YoY
- -65.17%
- Net profit QoQ
- +0.22%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.48% | — |
| 3 days | -5.11% | — |
| 7 days | +0.00% | — |
| 14 days | -4.82% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.31%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥61.80M | -63.30% | -65.17% | +24.88% | 0.21 | 1.92% | -5.11% | — | — |
| 2026 interim report | 2026-08-21 | ¥41.96M | -68.61% | -72.78% | +32.98% | 0.14 | 1.30% | -0.63% | +7.43% | +13.14% |
| 2026 Q1 report | 2026-04-30 | ¥22.17M | -72.64% | -75.02% | +45.35% | 0.07 | 0.68% | +6.73% | -27.75% | -29.80% |
| 2025 annual report | 2026-04-24 | ¥200.30M | -25.40% | -33.50% | +49.15% | 0.66 | 6.28% | -1.18% | -26.49% | -26.91% |
| 2025 Q3 report | 2025-10-29 | ¥168.38M | -9.91% | -16.19% | +40.52% | 0.57 | 5.21% | -3.31% | -17.45% | -13.98% |
| 2025 interim report | 2025-08-22 | ¥133.71M | -3.38% | -6.56% | +37.32% | 0.45 | 4.13% | +8.68% | +5.99% | -1.81% |
| 2025 Q1 report | 2025-04-28 | ¥81.04M | +1.30% | +0.19% | +28.63% | 0.27 | 2.47% | +3.29% | +11.23% | +7.98% |
| 2024 annual report | 2025-02-28 | ¥268.48M | -27.72% | -27.46% | +0.93% | 0.90 | 8.55% | +1.98% | -3.70% | +3.34% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.